Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Number of holders
-
282
-
Total 13F shares, excl. options
-
102,126,793
-
Shares change
-
-6,683,646
-
Total reported value, excl. options
-
$3,952,163,523
-
Value change
-
-$223,082,374
-
Put/Call ratio
-
360%
-
Number of buys
-
135
-
Number of sells
-
-143
-
Price
-
$38.92
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2014
351 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q2 2014.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 282 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 102,126,793 shares
.
Largest 10 shareholders include ROYCE & ASSOCIATES LLC (9,299,478 shares), BAILLIE GIFFORD & CO (8,785,503 shares), Capital Research Global Investors (8,717,609 shares), Capital World Investors (5,295,079 shares), VANGUARD GROUP INC (5,050,663 shares), SCOPIA CAPITAL MANAGEMENT LLC (2,851,267 shares), FIRST TRUST ADVISORS LP (2,846,052 shares), IRIDIAN ASSET MANAGEMENT LLC/CT (2,696,216 shares), TIGER GLOBAL MANAGEMENT LLC (1,900,000 shares), and BlackRock Institutional Trust Company, N.A. (1,872,432 shares).
This table shows the top 282 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.